Elena(Shulyak)MeadMD

Critical Care Medicine, Pleural Disease

Physician

Dr. Mead is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1275 York Ave
New York, NY 10065
Phone+1 212-639-6673

Fax+1 718-920-2058

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Pulmonary Disease and Critical Care Medicine, 2007 - 2010
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2003 - 2006
University of Massachusetts Medical SchoolClass of 2003

PubMed

143 citations
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
Marcela V. Maus, Sara Alexander, Michael R. Bishop, Jennifer N. Brudno, Colleen Callahan
Journal for Immunotherapy of Cancer. 2020-12-01
1731 citations
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
Daniel W. Lee, Bianca Santomasso, Frederick L. Locke, Armin Ghobadi, Cameron J. Turtle
Biology of Blood and Marrow Transplantation. 2019-04-01
1652 citations
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park, Isabelle Riviere, Mithat Gonen, Xiuyan Wang, Brigitte Senechal
The New England Journal of Medicine. 2018-01-31

Abstracts/Posters

Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Vulnerable Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Elena Mead, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T Cells
Elena Mead, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Comparing Gradings of Immune Effector Cells Toxicities: Application of Astct Consensus Grading System and Implications for Clinical Management
Elena Mead, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Hematological Count Recovery in Patients Undergoing Treatment with Chimeric Antigen Receptor T Cells (CAR T)
Elena Mead, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all